{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:19:48Z","timestamp":1763381988589,"version":"3.45.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"14-15","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.1080\/14656566.2025.2574849","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:30:44Z","timestamp":1760369444000},"page":"1493-1501","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Investigating cefepime\/taniborbactam for the treatment of complicated urinary tract infections"],"prefix":"10.1080","volume":"26","author":[{"given":"Claudia","family":"Bartalucci","sequence":"first","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Giurco","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vena","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89240-5"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020251"},{"key":"e_1_3_6_5_1","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual epidemiological report 2021. Stockholm: ECDC; 2022."},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.11.009"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2024.2407068"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1563071"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad262"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00115-20"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30868-9"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000001056"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02534-16"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01963-19"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae329"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01281-22"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa373"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01053-21"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304748"},{"key":"e_1_3_6_22_1","unstructured":"Food and Drug Administration. Complicated urinary tract infections: developing drugs for treatment. Guidance document. 2018. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/complicated-urinary-tract-infections-developing-drugs-treatment"},{"key":"e_1_3_6_23_1","unstructured":"European Medicines Agency. Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. Ema\/844951 rev. 3. 2018. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-evaluation-medicinal-products-indicated-treatment-bacterial-infections-revision-3_en.pdf"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02082-9"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6909528"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040463"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa511"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3548-3554.2001"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.007"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.03.011"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000885"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00751-24"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00069-5"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00991-23"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00579-23"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01168-23"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02179-21"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab405"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac446"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00253-22"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00061-25"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2403590"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2403590"},{"issue":"20","key":"e_1_3_6_44_1","first-page":"1938","article-title":"Cefepime-taniborbactam in complicated urinary tract infection","volume":"390","author":"Manesh A","year":"2024","unstructured":"Manesh A, Varghese GM, Paterson DL. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390(20):1938.","journal-title":"N Engl J Med"},{"key":"e_1_3_6_45_1","unstructured":"Cefepime for injection. (NY): Pfizer; 2019. Available from https:\/\/labeling.pf izer.com\/ShowLabeling.aspx?id=13898"},{"issue":"20","key":"e_1_3_6_46_1","first-page":"1938","article-title":"Cefepime-taniborbactam in complicated urinary tract infection","volume":"390","author":"Wagenlehner FM","year":"2024","unstructured":"Wagenlehner FM, McGovern PC, Moeck G. Cefepime-taniborbactam in complicated urinary tract infection. Reply N Engl J Med. 2024;390(20):1938\u20131939.","journal-title":"Reply N Engl J Med"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00236-24"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S205309"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf250"},{"key":"e_1_3_6_50_1","unstructured":"Venatorx Pharmaceuticals. Venatorx and Melinta provide update on status of U.S. new drug application for cefepime-taniborbactam. [cited 2025 May 28]. Available from: https:\/\/venatorx.com\/press-releases\/venatorx-and-melinta-provide-update-on-status-of -u-s-new-drug-application-for-cefepime-taniborbactam\/"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2574849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:17:17Z","timestamp":1763381837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2574849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":48,"journal-issue":{"issue":"14-15","published-print":{"date-parts":[[2025,10,13]]}},"alternative-id":["10.1080\/14656566.2025.2574849"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2574849","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"type":"print","value":"1465-6566"},{"type":"electronic","value":"1744-7666"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}